REGISTERED NUMBER: SC358238 (Scotland)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

PULSE PHARMACY LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

N Ahmad

Mrs A Ahmad

REGISTERED OFFICE:

10 Newdyke Road

Kirkintilloch

Glasgow

G66 2PX

REGISTERED NUMBER:

SC358238 (Scotland)

FIXED ASSETS

Tangible assets

4

184,375

210,196

Investments

5

122,352

107,350

306,727

317,546

CURRENT ASSETS

Stocks

6

58,054

55,054

Debtors

7

362,723

358,650

Cash at bank and in hand

322,587

372,061

743,364

785,765

CREDITORS

Amounts falling due within one year

8

297,664

245,486

NET CURRENT ASSETS

445,700

540,279

TOTAL ASSETS LESS CURRENT LIABILITIES

752,427

857,825

CREDITORS

Amounts falling due after more than one year

9

(45,672

)

(58,590

)

PROVISIONS FOR LIABILITIES

10

(2,890

)

(1,181

)

NET ASSETS

703,865

798,054

CAPITAL AND RESERVES

Called up share capital

200

200

Retained earnings

703,665

797,854

SHAREHOLDERS' FUNDS

703,865

798,054

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 October 2025 and were signed on its behalf by:

N Ahmad - Director

1.	STATUTORY INFORMATION

Pulse Pharmacy Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Freehold property

-

2% on cost

Improvements to property

-

20% on reducing balance

Plant and machinery

-

20% on reducing balance

Fixtures and fittings

-

20% on reducing balance

Motor vehicles

-

25% on reducing balance

Computer equipment

-

20% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the statement of Income and Retained Earnings.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2024 - 18 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Freehold

to

Plant and

property

property

machinery

£

£

£

COST

At 1 April 2024

149,450

5,880

30,988

Additions

-

-

-

At 31 March 2025

149,450

5,880

30,988

DEPRECIATION

At 1 April 2024

35,868

5,488

27,962

Charge for year

2,989

78

605

At 31 March 2025

38,857

5,566

28,567

NET BOOK VALUE

At 31 March 2025

110,593

314

2,421

At 31 March 2024

113,582

392

3,026

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

£

£

£

COST

At 1 April 2024

84,639

120,024

18,230

409,211

Additions

-

-

231

231

At 31 March 2025

84,639

120,024

18,461

409,442

DEPRECIATION

At 1 April 2024

75,579

44,168

9,950

199,015

Charge for year

1,812

18,882

1,686

26,052

At 31 March 2025

77,391

63,050

11,636

225,067

NET BOOK VALUE

At 31 March 2025

7,248

56,974

6,825

184,375

At 31 March 2024

9,060

75,856

8,280

210,196

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Motor

vehicles

£

COST

At 1 April 2024

and 31 March 2025

95,145

DEPRECIATION

At 1 April 2024

39,143

Charge for year

14,001

At 31 March 2025

53,144

NET BOOK VALUE

At 31 March 2025

42,001

At 31 March 2024

56,002

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 April 2024

107,350

Additions

15,002

At 31 March 2025

122,352

NET BOOK VALUE

At 31 March 2025

122,352

At 31 March 2024

107,350

6.

STOCKS

2025

2024

£

£

Stocks

58,054

55,054

7.

DEBTORS

2025

2024

£

£

Amounts falling due within one year:

Directors' current accounts

235,848

269,244

VAT

79,828

43,206

Prepayments

1,991

1,144

317,667

313,594

Amounts falling due after more than one year:

Recoverable tax

45,056

45,056

Aggregate amounts

362,723

358,650

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Hire purchase contracts

12,918

10,383

Trade creditors

200,774

138,404

Tax

58,671

62,306

Social security and other taxes

3,716

3,896

Other creditors

760

13,190

Accrued expenses

20,825

17,307

297,664

245,486

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Hire purchase contracts

45,672

58,590

10.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

2,890

1,181

Deferred

tax

£

Balance at 1 April 2024

1,181

Charge to Income Statement during year

1,709

Balance at 31 March 2025

2,890

11.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025

2024

£

£

N Ahmad

Balance outstanding at start of year

269,244

138,633

Amounts advanced

-

130,611

Amounts repaid

(33,396

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

235,848

269,244